Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Rubinstein

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
B cells imprint adoptively transferred CD8<sup>+</sup> T cells with enhanced tumor immunityAubrey S Smith, Hannah M Knochelmann, Megan M Wyatt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy VolunteersMark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Oncoimmunology|August 19, 2021
Modeling <i>ex vivo</i> tumor-infiltrating lymphocyte expansion from established solid malignanciesHannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt, et al.
The Journal of Biological Chemistry|April 12, 2019
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cellsParamita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
Cancer Research|July 29, 2016
Lack of p53 Augments Antitumor Functions in Cytolytic T CellsAnirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, et al.
Iscience|May 10, 2021
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patientsConnor J Dwyer, Colleen A Cloud, Cindy Wang, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
B cells imprint adoptively transferred CD8<sup>+</sup> T cells with enhanced tumor immunityAubrey S Smith, Hannah M Knochelmann, Megan M Wyatt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy VolunteersMark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Oncoimmunology|August 19, 2021
Modeling <i>ex vivo</i> tumor-infiltrating lymphocyte expansion from established solid malignanciesHannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt, et al.
The Journal of Biological Chemistry|April 12, 2019
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cellsParamita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
Cancer Research|July 29, 2016
Lack of p53 Augments Antitumor Functions in Cytolytic T CellsAnirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, et al.
Iscience|May 10, 2021
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patientsConnor J Dwyer, Colleen A Cloud, Cindy Wang, et al.
Pageof 8